On December 2, 2019 NexImmune, a clinical stage immunotherapy company developing novel T cell therapies, reported that Scott Carmer, Neximmune’s Chief Executive Officer, will be particpating and presenting a corporate update at the following conferences (Press release, NexImmune, DEC 2, 2019, View Source [SID1234554875]). A webcast of Wednesday’s presentation will be available on the Company’s website under the News & Events tab.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Piper Jaffray’s 31st Annual Healthcare Conference
Tuesday, December 3rd, 3:50PM ET
New York, NY

Evercore’s 2nd Annual HealthCONx Conference
Wednesday, December 4th, 3:50PM ET
Boston, MA